Is obesity a disease or a choice? Why is weight loss so difficult to maintain? What roles do hormones play within the gut-brain axis in the pathophysiology of obesity? What are the comorbidities associated with obesity? And why does the obesity epidemic continue to grow despite a wealth of information? Join series host Dr Robert Kushner, Medical Director of the Center for Lifestyle Medicine at Northwestern Medicine in Chicago, as he interviews fellow experts in the field of obesity on how they tackle everyday challenges when treating patients with obesity and shares advice on how clinicians can optimize patient outcomes in this ever-evolving disease area.
This podcast is sponsored and developed by Novo Nordisk and is intended for clinicians. The opinions expressed are those of the speakers and not Novo Nordisk. The moderator and discussants have been compensated for their participation in this podcast.
EPISODE 1:
Join experts in obesity, Dr Robert Kushner, Dr Eric Ravussin, and Dr Jeffrey Sicat as they discuss the science behind metabolic adaption and why this makes weight loss so difficult to maintain over time.
- Robert Kushner, MD
- Eric Ravussin, PhD
- Jeffrey Sicat, MD, FACE
This podcast is sponsored by Novo Nordisk and is intended for clinicians.
EPISODE 2:
Join experts in obesity, Dr Robert Kushner, Dr Leigh Perreault, and Dr Robert Busch as they discuss the pathophysiology of obesity, with a focus on how dysfunctional adipose tissue can lead to metabolic complications, as well as a discussion on the role of the gut-brain axis in regulating appetite and eating behavior.
- Robert Kushner, MD
- Leigh Perreault, MD
- Robert Busch, MD
This podcast is sponsored by Novo Nordisk and is intended for clinicians.
EPISODE 3:
Join experts in obesity Dr Robert Kushner, Dr Louis Aronne, and Dr Jamy Ard as they raise awareness about obesity as a chronic, progressive disease with biological and environmental components.
- Robert Kushner, MD
- Jamy Ard, MD
- Louis Aronne, MD, FACP, DABOM
This podcast is sponsored by Novo Nordisk and is intended for clinicians.
Novo Nordisk is a registered trademark of Novo Nordisk A/S. All other trademarks, registered or unregistered, are the property of their respective owners. © 2024 Novo Nordisk All rights reserved. US24OB00077 February 2024
